Michael Schmidt
Stock Analyst at Guggenheim
(4.25)
# 373
Out of 4,868 analysts
111
Total ratings
61.18%
Success rate
11.22%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Schmidt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ADCT ADC Therapeutics | Maintains: Buy | $7 → $10 | $3.03 | +230.03% | 5 | Jun 13, 2025 | |
| URGN UroGen Pharma | Maintains: Buy | $40 → $15 | $14.87 | +0.87% | 1 | May 23, 2025 | |
| MRSN Mersana Therapeutics | Reiterates: Buy | $5 | $0.36 | +1,304.10% | 3 | May 16, 2025 | |
| KYMR Kymera Therapeutics | Reiterates: Buy | $52 | $46.44 | +11.97% | 1 | May 12, 2025 | |
| SWTX SpringWorks Therapeutics | Reiterates: Neutral | $47 | $46.78 | +0.47% | 3 | May 12, 2025 | |
| CMPX Compass Therapeutics | Maintains: Buy | $12 → $10 | $2.38 | +320.17% | 4 | May 9, 2025 | |
| ONC BeOne Medicines | Maintains: Buy | $348 → $350 | $252.94 | +38.37% | 3 | May 8, 2025 | |
| RVMD Revolution Medicines | Maintains: Buy | $87 → $80 | $39.93 | +100.35% | 3 | May 8, 2025 | |
| RLAY Relay Therapeutics | Maintains: Buy | $30 → $10 | $3.36 | +197.62% | 1 | May 7, 2025 | |
| SNDX Syndax Pharmaceuticals | Reiterates: Buy | $32 | $9.69 | +230.24% | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $16 | $7.47 | +114.19% | 5 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $4.29 | +86.48% | 2 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $109 | $52.59 | +107.26% | 5 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $1.75 | $0.26 | +583.59% | 3 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $5.19 | +169.75% | 3 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $25 | $8.83 | +183.13% | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $92 | $68.27 | +34.76% | 5 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $34.89 | - | 1 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $24.94 | +80.43% | 1 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $9.22 | - | 5 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $40.74 | +3.09% | 10 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $0.59 | - | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $128.12 | - | 2 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.98 | +571.14% | 1 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $1.38 | +479.71% | 3 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $31.70 | - | 3 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.66 | - | 2 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.77 | - | 2 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.29 | - | 1 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $34 | $8.36 | +306.94% | 4 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 | $0.67 | +2,889.54% | 3 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $21.56 | - | 2 | Jan 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $1.41 | +1,679.36% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $4.49 | +568.15% | 1 | Jul 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $3.05 | +752.46% | 1 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.40 | - | 2 | Apr 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $80 | $35.46 | +125.61% | 5 | Feb 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $7.54 | - | 6 | Jan 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $4 → $5.5 | $3.47 | +58.50% | 2 | Nov 7, 2017 |
ADC Therapeutics
Jun 13, 2025
Maintains: Buy
Price Target: $7 → $10
Current: $3.03
Upside: +230.03%
UroGen Pharma
May 23, 2025
Maintains: Buy
Price Target: $40 → $15
Current: $14.87
Upside: +0.87%
Mersana Therapeutics
May 16, 2025
Reiterates: Buy
Price Target: $5
Current: $0.36
Upside: +1,304.10%
Kymera Therapeutics
May 12, 2025
Reiterates: Buy
Price Target: $52
Current: $46.44
Upside: +11.97%
SpringWorks Therapeutics
May 12, 2025
Reiterates: Neutral
Price Target: $47
Current: $46.78
Upside: +0.47%
Compass Therapeutics
May 9, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $2.38
Upside: +320.17%
BeOne Medicines
May 8, 2025
Maintains: Buy
Price Target: $348 → $350
Current: $252.94
Upside: +38.37%
Revolution Medicines
May 8, 2025
Maintains: Buy
Price Target: $87 → $80
Current: $39.93
Upside: +100.35%
Relay Therapeutics
May 7, 2025
Maintains: Buy
Price Target: $30 → $10
Current: $3.36
Upside: +197.62%
Syndax Pharmaceuticals
May 6, 2025
Reiterates: Buy
Price Target: $32
Current: $9.69
Upside: +230.24%
May 2, 2025
Maintains: Buy
Price Target: $32 → $16
Current: $7.47
Upside: +114.19%
Apr 4, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $4.29
Upside: +86.48%
Mar 28, 2025
Reiterates: Buy
Price Target: $109
Current: $52.59
Upside: +107.26%
Mar 26, 2025
Maintains: Buy
Price Target: $3 → $1.75
Current: $0.26
Upside: +583.59%
Mar 24, 2025
Maintains: Buy
Price Target: $13 → $14
Current: $5.19
Upside: +169.75%
Mar 20, 2025
Maintains: Buy
Price Target: $35 → $25
Current: $8.83
Upside: +183.13%
Mar 18, 2025
Downgrades: Neutral
Price Target: $92
Current: $68.27
Upside: +34.76%
Mar 12, 2025
Reiterates: Neutral
Price Target: n/a
Current: $34.89
Upside: -
Mar 10, 2025
Initiates: Buy
Price Target: $45
Current: $24.94
Upside: +80.43%
Feb 26, 2025
Reiterates: Buy
Price Target: n/a
Current: $9.22
Upside: -
Feb 12, 2025
Reiterates: Buy
Price Target: $42
Current: $40.74
Upside: +3.09%
Jan 22, 2025
Reiterates: Buy
Price Target: n/a
Current: $0.59
Upside: -
Dec 11, 2024
Reiterates: Buy
Price Target: n/a
Current: $128.12
Upside: -
Dec 6, 2024
Reiterates: Buy
Price Target: $20
Current: $2.98
Upside: +571.14%
Nov 15, 2024
Maintains: Buy
Price Target: $12 → $8
Current: $1.38
Upside: +479.71%
Oct 7, 2024
Downgrades: Neutral
Price Target: n/a
Current: $31.70
Upside: -
May 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.66
Upside: -
Mar 14, 2024
Downgrades: Neutral
Price Target: n/a
Current: $2.77
Upside: -
Jan 5, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.29
Upside: -
Nov 8, 2023
Maintains: Buy
Price Target: $40 → $34
Current: $8.36
Upside: +306.94%
Jun 27, 2023
Downgrades: Neutral
Price Target: $20
Current: $0.67
Upside: +2,889.54%
Jan 3, 2022
Downgrades: Neutral
Price Target: n/a
Current: $21.56
Upside: -
Aug 10, 2021
Initiates: Buy
Price Target: $25
Current: $1.41
Upside: +1,679.36%
Jul 19, 2021
Initiates: Buy
Price Target: $30
Current: $4.49
Upside: +568.15%
May 18, 2021
Initiates: Buy
Price Target: $26
Current: $3.05
Upside: +752.46%
Apr 28, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.40
Upside: -
Feb 15, 2019
Upgrades: Outperform
Price Target: $80
Current: $35.46
Upside: +125.61%
Jan 17, 2019
Initiates: Outperform
Price Target: n/a
Current: $7.54
Upside: -
Nov 7, 2017
Maintains: Market Perform
Price Target: $4 → $5.5
Current: $3.47
Upside: +58.50%